Inpatient pulmonary embolism after elective primary total hip and knee arthroplasty in the United States

Journal of Bone and Joint Surgery

Volumn 95, Issue 22, 2013, Pages

  Zahir, Usman ^a   Sterling, Robert S ^a   Pellegrini, Vincent D ^a   Forte, Mary L ^a  

^a UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; ARTICLE; CHARLSON COMORBIDITY INDEX; COHORT ANALYSIS; ELECTIVE SURGERY; FEMALE; HEART ATRIUM FIBRILLATION; HOSPITAL ADMISSION; HOSPITAL DISCHARGE; HOSPITALIZATION; HUMAN; LENGTH OF STAY; LUNG EMBOLISM; MAJOR CLINICAL STUDY; MALE; MORTALITY; OUTCOME ASSESSMENT; PRIORITY JOURNAL; RETROSPECTIVE STUDY; TOTAL HIP PROSTHESIS; TOTAL KNEE REPLACEMENT; UNITED STATES; HIP ARTHROPLASTY; INCIDENCE; KNEE ARTHROPLASTY; PULMONARY EMBOLISM; RISK FACTOR; STATISTICS AND NUMERICAL DATA;

AGED; ARTHROPLASTY, REPLACEMENT, HIP; ARTHROPLASTY, REPLACEMENT, KNEE; COHORT STUDIES; ELECTIVE SURGICAL PROCEDURES; FEMALE; HOSPITALIZATION; HUMANS; INCIDENCE; MALE; PULMONARY EMBOLISM; RETROSPECTIVE STUDIES; RISK FACTORS; UNITED STATES;

EID: 84894679716     PISSN: 00219355     EISSN: 15351386     Source Type: Journal    
DOI: 10.2106/JBJS.L.00466     Document Type: Article

References (58)

1. Huo MH, Dumont GD, Knight JR, Mont MA. What's new in total hip arthroplasty. J Bone Joint Surg Am. 2011 Oct 19;93(20):1944-50.
2. Losina E, Thornhill TS, Rome BN, Wright J, Katz JN. The dramatic increase in total knee replacement utilization rates in the United States cannot be fully explained by growth in population size and the obesity epidemic. J Bone Joint Surg Am. 2012 Feb 1;94(3):201-7.
3. Kurtz S, Ong K, Lau E, Mowat F, HalpernM. Projections of primary and revision hip and knee arthroplasty in the United States from 2005 to 2030. J Bone Joint Surg Am. 2007 Apr;89(4):780-5.
4. Katz JN, Barrett J, Mahomed NN, Baron JA, Wright RJ, Losina E. Association between hospital and surgeon procedure volume and the outcomes of total knee replacement. J Bone Joint Surg Am. 2004 Sep;86(9):1909-16.
5. Katz JN, Losina E, Barrett J, Phillips CB, Mahomed NN, Lew RA, Guadagnoli E, Harris WH, Poss R, Baron JA. Association between hospital and surgeon procedure volume and outcomes of total hip replacement in the United States medicare population. J Bone Joint Surg Am. 2001 Nov;83(11):1622-9.
6. Geerts WH, Pineo GF, Heit JA, Bergqvist D, Lassen MR, Colwell CW, Ray JG. Prevention of venous thromboembolism: The Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy. Chest. 2004 Sep;126(3)(Suppl): 338S-400S.
7. White RH, Romano PS, Zhou H, Rodrigo J, Bargar W. Incidence and time course of thromboembolic outcomes following total hip or knee arthroplasty. Arch Intern Med. 1998 Jul 27;158(14):1525-31.
8. Warwick D, Friedman RJ, Agnelli G, Gil-Garay E, Johnson K, FitzGerald G, Turibio FM. Insufficient duration of venous thromboembolism prophylaxis after total hip or knee replacement when compared with the time course of thromboembolic events: Findings from the Global Orthopaedic Registry. J Bone Joint Surg Br. 2007 Jun;89(6):799-807.
9. Kearon C. Natural history of venous thromboembolism. Circulation. 2003 Jun 17;107(23)(Suppl 1):I22-30.
10. Lachiewicz PF. Prevention of symptomatic pulmonary embolism in patients undergoing total hip and knee arthroplasty: Clinical guideline of the American Academy of Orthopaedic Surgeons. Instr Course Lect. 2009;58:795-804.
11. Pellegrini VD Jr, Clement D, Lush-Ehmann C, Keller GS, Evarts CM. The John Charnley Award. Natural history of thromboembolic disease after total hip arthroplasty. Clin Orthop Relat Res. 1996 Dec;(333):27-40.
12. Pellegrini VD Jr, Donaldson CT, Farber DC, Lehman EB, Evarts CM. The John Charnley Award: Prevention of readmission for venous thromboembolic disease after total hip arthroplasty. Clin Orthop Relat Res. 2005 Dec;(441): 56-62.
13. Pellegrini VD Jr, Donaldson CT, Farber DC, Lehman EB, Evarts CM. The Mark Coventry Award: Prevention of readmission for venous thromboembolism after total knee arthroplasty. Clin Orthop Relat Res. 2006 Nov;(452):21-7.
14. Januel JM, Chen G, Ruffieux C, Quan H, Douketis JD, Crowther MA, Colin C, Ghali WA, Burnand B. IMECCHI Group. Symptomatic in-hospital deep vein thrombosis and pulmonary embolism following hip and knee arthroplasty among patients receiving recommended prophylaxis: A systematic review. JAMA. 2012 Jan 18;307(3):294-303.
15. Hervey SL, Purves HR, Guller U, Toth AP, Vail TP, Pietrobon R. Provider Volume of Total Knee Arthroplasties and Patient Outcomes in the HCUP-Nationwide Inpatient Sample. J Bone Joint Surg Am. 2003 Sep;85(9):1775-83.
16. Memtsoudis SG, Besculides MC, Gaber L, Liu S, Gonźalez Della Valle A. Risk factors for pulmonary embolism after hip and knee arthroplasty: A population-based study. Int Orthop. 2009 Dec;33(6):1739-45. Epub 2008 Oct 17.
17. Goldhaber SZ, Savage DD, Garrison RJ, Castelli WP, Kannel WB, McNamara PM, Gherardi G, Feinleib M. Risk factors for pulmonary embolism. The Framingham Study. Am J Med. 1983 Jun;74(6):1023-8.
18. Pedersen AB, Sorensen HT, Mehnert F, Overgaard S, Johnsen SP. Risk factors for venous thromboembolism in patients undergoing total hip replacement and receiving routine thromboprophylaxis. J Bone Joint Surg Am. 2010 Sep 15;92(12):2156-64.
19. Memtsoudis SG, Della Valle AG, Besculides MC, Esposito M, Koulouvaris P, Salvati EA. Risk factors for perioperative mortality after lower extremity arthroplasty: A population-based study of 6,901,324 patient discharges. J Arthroplasty. 2010 Jan;25(1):19-26. Epub 2008 Dec 23.
20. Center for Medicare & Medicaid Services (CMS) - Correspondence Letter. July 31, 2008, 1-5. http://downloads.cms.gov/cmsgov/archived-downloads/ SMDL/downloads/SMD073108.pdf. Accessed: 2012 Oct 28.
21. Goldhaber SZ, Turpie AGG. Prevention of venous thromboembolism among hospitalized medical patients. Circulation. 2005 Jan 4;111(1):e1-3.
22. Murray D, Britton A, Bulstrode C. Thromboprophylaxis and death after total hip replacement. J Bone Joint Surg Br. 1996 Nov;78(6):863-70.
23. Healthcare Cost and Utilization Project (HCUP). HCUP Nationwide Inpatient Sample (NIS). http://www.hcup-us.ahrq.gov/db/nation/nis/nisdbdocumentation. jsp. Accessed 2013 May 24.
24. Healthcare Cost and Utilization Project (HCUP). 2007 Introduction to the NIS. http://www.hcup-us.ahrq.gov/db/nation/nis/NIS-Introduction-2007.jsp. Accessed 2013 May 24.
25. Ingenix Medicode. 2001 physician ICD-9-CM, volumes 1&2. 6th ed. Valley Stream, NY: Medicode; 2000.
26. White RH. The epidemiology of venous thromboembolism. Circulation. 2003 Jun 17;107(23)(Suppl 1):I4-8.
27. White RH, Zhou H, Romano PS. Incidence of symptomatic venous thromboembolism after different elective or urgent surgical procedures. Thromb Haemost. 2003 Sep;90(3):446-55.
28. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: Development and validation. J Chronic Dis. 1987;40(5):373-83.
29. Deyo RA, Cherkin DC, Ciol MA. Adapting a clinical comorbidity index for use with ICD-9-CM administrative databases. J Clin Epidemiol. 1992 Jun;45(6):613-9.
30. Needham DM, Scales DC, Laupacis A, Pronovost PJ. A systematic review of the Charlson comorbidity index using Canadian administrative databases: A perspective on risk adjustment in critical care research. J Crit Care. 2005Mar;20(1): 12-9.
31. Howie C, Hughes H, Watts AC. Venous thromboembolism associated with hip and knee replacement over a ten-year period: A population-based study. J Bone Joint Surg Br. 2005 Dec;87(12):1675-80.
32. SooHoo NF, Lieberman JR, Ko CY, Zingmond DS. Factors predicting complication rates following total knee replacement. J Bone Joint Surg Am. 2006 Mar;88(3):480-5.
33. Romano PS, Roos LL, Jollis JG. Adapting a clinical comorbidity index for use with ICD-9-CM administrative data: Differing perspectives. J Clin Epidemiol. 1993 Oct;46(10):1075-9, discussion :1081-90.
34. Gex G, Gerstel E, Righini M, LE Gal G, Aujesky D, Roy PM, Sanchez O, Verschuren F, Rutschmann OT, Perneger T, Perrier A. Is atrial fibrillation associated with pulmonary embolism? J Thromb Haemost. 2012 Mar;10(3):347-51.
35. Beksacx B, Gonźalez Della Valle A, Salvati EA. Thromboembolic disease after total hip arthroplasty: Who is at risk? Clin Orthop Relat Res. 2006 Dec;(453):211-24.
36. Eisele R, Melzer N, Englert C, Bramlage P, Spannagl M. Bridging with the Low molecular weight heparin certoparin in patients requiring temporary discontinuation of oral anticoagulation - the non-interventional, retrospective REMEMBER study. Thromb Res. 2012 Nov;130(5):788-92. Epub 2012 Jan 26.
37. Chen X, Gorrell P. An introduction to the SAS- survey analysis PROCs. 2008.
38. http://www.nesug.org/proceedings/nesug08/sa/sa06.pdf. Accessed 2012 Mar 27.
39. Allison PD. Logistic regression using the SAS- system: Theory and application. SAS Institute: Cary, NY; 2001.
40. Zhang J, Yu KF. What's the relative risk? A method of correcting the odds ratio in cohort studies of common outcomes. JAMA. 1998 Nov 18;280(19):1690-1.
41. Department of Health and Human Services. Centers for Medicare & Medicaid Services. Deep vein thrombosis/pulmonary embolism. Fed Regist. 2008;73(161):48480-2. http://edocket.access.gpo.gov/2008/pdf/E8-17914. pdf. Accessed 2012 Feb 13.
42. Khatod M, Inacio MC, Bini SA, Paxton EW. Prophylaxis against pulmonary embolism in patients undergoing total hip arthroplasty. J Bone Joint Surg Am. 2011 Oct 5;93(19):1767-72.
43. Mraovic B, Hipszer BR, Epstein RH, Pequignot EC, Parvizi J, Joseph JI. Preadmission hyperglycemia is an independent risk factor for in-hospital symptomatic pulmonary embolism after major orthopedic surgery. J Arthroplasty. 2010 Jan;25(1):64-70. Epub 2008 Dec 04.
44. Messieh M. Preoperative risk factors associated with symptomatic pulmonary embolism after total knee arthroplasty. Orthopedics. 1999 Dec;22(12):1147-9.
45. Restrepo C, Parvizi J, Dietrich T, Einhorn TA. Safety of simultaneous bilateral total knee arthroplasty. A meta-analysis. J Bone Joint Surg Am. 2007 Jun;89(6):1220-6.
46. Mantilla CB, Horlocker TT, Schroeder DR, Berry DJ, Brown DL. Frequency of myocardial infarction, pulmonary embolism, deep venous thrombosis, and death following primary hip or knee arthroplasty. Anesthesiology. 2002 May;96(5):1140-6.
47. Lane GJ, Hozack WJ, Shah S, Rothman RH, Booth RE Jr, Eng K, Smith P. Simultaneous bilateral versus unilateral total knee arthroplasty. Outcomes analysis. Clin Orthop Relat Res. 1997 Dec;(345):106-12.
48. Urban MK, Chisholm M, Wukovits B. Are postoperative complications more common with single-stage bilateral (SBTKR) than with unilateral knee arthroplasty: Guidelines for patients scheduled for SBTKR. HSS J. 2006 Feb;2(1):78-82.
49. Keenan CR, White RH. The effects of race/ethnicity and sex on the risk of venous thromboembolism. Curr Opin Pulm Med. 2007 Sep;13(5):377-83.
50. Niki Y, Matsumoto H, Hakozaki A, Mochizuki T, Momohara S. Rheumatoid arthritis: A risk factor for deep venous thrombosis after total knee arthroplasty? Comparative study with osteoarthritis. J Orthop Sci. 2010 Jan;15(1):57-63. Epub 2010 Feb 12.
51. Fang MC, Singer DE, Chang Y, Hylek EM, Henault LE, Jensvold NG, Go AS. Gender differences in the risk of ischemic stroke and peripheral embolism in atrial fibrillation: The AnTicoagulation and Risk factors In Atrial fibrillation (ATRIA) study. Circulation. 2005 Sep 20;112(12):1687-91. Epub 2005 Sep 12.
52. Genewein U, Haeberli A, Straub PW, Beer JH. Rebound after cessation of oral anticoagulant therapy: The biochemical evidence. Br J Haematol. 1996 Feb;92(2):479-85.
53. Kearon C, Hirsh J. Management of anticoagulation before and after elective surgery. N Engl J Med. 1997 May 22;336(21):1506-11.
54. Palareti G, Legnani C, Guazzaloca G, Frascaro M, Grauso F, De Rosa F, Fortunato G, Coccheri S. Activation of blood coagulation after abrupt or stepwise withdrawal of oral anticoagulants - a prospective study. Thromb Haemost. 1994 Aug;72(2):222-6.
55. Grip L, BlombackM, Schulman S. Hypercoagulable state and thromboembolism following warfarin withdrawal in post-myocardial-infarction patients. Eur Heart J. 1991 Nov;12(11):1225-33.
56. Pellegrini VD, Thompson S, Lisi M, Sterling R, Terrin M. Acute pulmonary embolism following total joint arthroplasty: Chronic preoperative warfarin as a risk factor for in-hospital events. Presented at the 12th meeting of the Combined Orthopaedic Associations; 2010 Sep 12-17; Glasgow,Scotland.
57. KirkseyM, Chiu YL, Ma Y, Della Valle AG, Poultsides L, Gerner P,Memtsoudis SG. Trends in in-hospital major morbidity and mortality after total joint arthroplasty: United States 1998-2008. Anesth Analg. 2012 Aug;115(2):321-7. Epub 2012 May 31.
58. Memtsoudis SG, Mantilla CB, Parvizi J, Stundner O, Mazumdar M. Have bilateral total knee arthroplasties become safer? A population-based trend analysis. Clin Orthop Relat Res. 2013 Jan;471(1):17-25. Epub 2012 Sep 25.